September 2018 - Page 5 of 8 - CannabisNewsWire

MondaySep 17, 2018 4:20 pm

420 with CNW – Study Finds Marijuana Use Among Older Americans Has Doubled

A study published recently in the journal Drug and Alcohol Dependence has revealed that the use of cannabis among older Americans has increased remarkably from the level where it was a decade earlier. The rise was 100 percent among baby boomers (those aged 50 to 64-years), since cannabis use prevalence rose from 4.5 percent a decade ago to 9 percent, according to data collected from 2015 to 2016. Older adults (those aged 65 and above) increased their use of cannabis exponentially from 0.4 percent in 2005/2006 to nearly 3 percent 10 years later. It is also noteworthy that more than…

MondaySep 17, 2018 12:45 pm

Emerald Health Therapeutics Inc. (TSX.V: EMH) (OTCQX: EMHTF) Expands as Cannabis Supplier and Grows JV Production Facility in Canada

EMHTF named as a cannabis supplier for Newfoundland Labrador Liquor Corporation (NLC) to serve the adult use market of the entire province of Newfoundland and Labrador Pure Sunfarms, in which EMHTF is a 50-50 joint venture partner, has received from Health Canada an amendment permitting it to expand its cannabis production area to 550,000 sq. ft. EMHTF already has supply agreements with the Canadian provinces of British Columbia and Ontario; as a cannabis producer, it is ramping up operating facilities in British Columbia and Quebec Emerald Health Therapeutics Inc. (TSX.V: EMH) (OTCQX: EMHTF) is well positioned in Canada in the…

MondaySep 17, 2018 12:10 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Building on Key Milestones in Sol-gel Cannabinoid Development

Cannabinoid molecule extraction, quantification mark early successes in PreveCeutical’s drug delivery development process PreveCeutical optimistic about prototypical spray applicators in development for cannabinoid therapies Clinical trials of cannabis-based therapeutics anticipated next year PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is celebrating the achievement of several key milestones in the development of the company’s proprietary Sol-gel program for the nasal delivery of select medications, where those medications can be expected to effectively reach the nervous system in order to accomplish their purposes in treating conditions ranging from anxiety to head concussion injuries, a company officer told market reporting outlet…

MondaySep 17, 2018 11:35 am

BLOCKStrain Technology Corp. (TSX.V: DNAX) (OTC: BKKSF) Platform Makes Cannabis Consumer Protection Possible

Legal cannabis market likely to be plagued by poor quality control DNAX technology tracks all stages of cannabis supply chain Platform already deployed by biosciences company Liberalization may be bringing cannabis consumption out of the shadows, but large parts of the supply chain remain hidden – an inconspicuous circumstance that poses great risk to consumers. In New Haven, Connecticut, about 100 people overdosed on “synthetic marijuana” recently, and they may have had no idea that their pot was “synthetic.” Synthetic marijuana can be made to look like the real thing. Technology from BLOCKStrain Technology Corp. (TSX.V: DNAX) (OTC: BKKSF) may…

MondaySep 17, 2018 10:57 am

Sugarmade, Inc. (SGMD) Eyes European Hydroponics Supply Growth in Europe, Projected to be a €115 Billion Cannabis Market by 2028

The company is entering the European hydroponics market as it expands its foothold in the cannabis supply marketplace through its first order program via Amazon UK SGMD estimates that its revenue will reach $30 million by 2019 with operating profitability and positive operating cash flow; it is increasing its commitment to the industrial hemp sector The European marijuana market is seen as becoming the largest cannabis market in the world, with more than $150 million invested already Sugarmade, Inc. (OTC: SGMD) is targeting the European hydroponics market, supplying multiple products for cultivators via its first order through the Amazon UK…

FridaySep 14, 2018 1:16 pm

Canopy Rivers Corporation is “One to Watch”

Partnership with Canopy Growth leverages the network, expertise and innovation capabilities of the world’s largest cannabis company Diversified portfolio of high-quality licensed cannabis producers, late-stage applicants, ancillary products and brands Investments tailored to meet unique needs of each counterparty while achieving positive cash flow, secured downside protection and upside equity optionality Access to an alternative investment vehicle characterized by early entry points, detailed counterparty due diligence and distinguished partners Canopy Rivers Corporation is the venture capital investment platform of Canopy Growth Corporation (TSX: WEED) (NYSE: CGC). Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities…

FridaySep 14, 2018 12:52 pm

Green Hygienics Holdings Inc. (GRYN) Announces New Additions to Management Team

Matthew Dole appointed as senior vice president of business development Jeff Palumbo appointed as chief technology officer New management part of a strategic plan to increase shareholder value and brand awareness Green Hygienics Holdings Inc. (OTC: GRYN), a cannabis cultivation company targeting the high-end medical and adult-use recreational market, recently announced that it has appointed two new professionals to its management team. Matthew Dole and Jeff Palumbo bring years of leadership experience to Green Hygienics Holdings. The full announcement can be viewed at http://cnw.fm/rXV0h. Appointed as senior vice president of business development and director, Matthew Dole is a highly skilled business…

FridaySep 14, 2018 12:26 pm

Cannabis Strategic Ventures, Inc. (NUGS) Fine-tunes Foray into Cannabis Space with Brand Specific Strategies, Acquisitions

Proprietary branding and partnership model for consumer-focused cannabis brands Expansion includes acquisition of Asher House Pet CBD brand of U.S. hemp-derived cannabidiol supplements for pets Footprint growing in billion-dollar Asian nutraceuticals market with Fitamins CBD brand Cannabis industry growing at accelerated rate, with North American market expected to top $47 billion by 2027 Cannabis Strategic Ventures, Inc. (OTC: NUGS) is making good on its commitment to stakeholders as it moves forward on a previously announced strategy to develop a proprietary branding and partnership model for consumer-specific cannabis brands and secure several strategic acquisitions. “Branding is becoming more important to the development…

FridaySep 14, 2018 11:49 am

ChineseInvestors.com, Inc. (CIIX) Focuses on Providing Financial Information and Services

ChineseInvestors.com is a fintech company It provides financial information for Chinese-speaking investors The company is in the process of spinning off its cannabidiol (CBD) division ChineseInvestors.com, Inc. (OTCQB: CIIX) is a fintech company that concentrates on providing financial information and services. Its focus is on operating the foremost financial information website for Chinese-speaking investors. The company provides real-time market commentary, analysis and education-related services via www.ChineseFN.com. ChineseInvestors.com has corporate offices in San Gabriel, California; New York, New York; and Shanghai, China. Furthermore, the company has recognized opportunities in the U.S. cannabis industry. It has worked to take advantage of the…

ThursdaySep 13, 2018 4:20 pm

420 with CNW – The Marijuana Bill Undergoes Congressional Vote

Today, the Judiciary Committee of congress is voting on the Medical Cannabis Research Act. The proposed legislation is sponsored by a Republican, Mathew Gaetz, and 40 more cosponsors from both sides of the house. The Medical Cannabis Research Act is primarily intended to remove the legal barriers to the licensing of other producers of marijuana for research purposes. Other related issues are also included in this landmark legislation. Players in cannabis medical research have previously complained that the single grower (University of Mississippi) of the plant is often unable to supply cannabis of an acceptable quality and volume for the…